Veeva Announces MyVeeva to Enable Patient-Centric Clinical Trials

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/31/2026

1. NVDA
2. PCG
3. AMZN
4. AAPL
5. AVGO
6. ALNY
7. CNS
8. STLA
9. EC
10. SPCX

Go back to Veeva Announces MyVeeva to Enable Patient-Centric Clinical Trials
VEEVA SYSTEMS, Inc. (NYSE: VEEV) Delayed: 285.69 +9.00 (3.25%)
Previous Close $276.69    52 Week High $42.58 
Open $274.79    52 Week Low $19.97 
Day High $290.47    P/E 9,523.00 
Day Low $273.60    EPS $0.03 
Volume 2,849,041